SIEN Sientra, Inc.

8.170.29 (+3.68%)
Close: November 21, 2019

Quote

Previous Close
$8.17
Day Range
$7.68-$8.22
52 Week Range
$4.78-$18.67
Volume
673,786
Avg Volume
768,565
Dividend TTM
-
Ex-Dividend Date
-

Valuation

Market Cap
$404.26M
Enterprise Value (EV)
$337.77M
PE Ratio
-
EV/EBITDA
-4.57
Price/Sales
5.72
Price/Book
6.04
PEG Ratio
-

Financials

Revenue
$68.13M
Gross Profit
$41.30M
EBITDA
-$73.92M
EPS, ttm
-$3.32
Profit Margin
-
Revenue/Employee
$263.03K
Next Earnings Date
3/11/2020 (110 days)
Debt to Equity
52%
Debt
$20.40M
Cash
$86.90M
Net Debt
-

Performance

Beta
1.49
200 Day Moving Avg
$7.39
50 Day Moving Avg
$6.87
52 Week Change
-54.24%
YTD Change
-38.55%
1 Month Change
18.50%
3 Month Change
10.83%
6 Month Change
8.99%
1 Year Change
-54.24%
2 Year Change
-43.43%
5 Year Change
-54.56%

Share Count

Shares Outstanding
49.5M
Float
43.0M
Restricted Shares
6.5M
Restricted Shares, %
13.05%

Sientra, Inc. Company Details

Sector: Health Technology

Industry: Medical Specialties

CEO: Jeffrey M. Nugent

Website: http://www.sientra.com

Description: Sientra, Inc. operates as a medical aesthetics company, which engages in developing and commercializing plastic surgery implantable devices. It operates through two reportable segments: Breast Products and miraDry. The Breast Products segment focuses on sales of its breast implants, tissue expanders and scar management products under the brands Sientra, AlloX2, Dermaspan, Softspan and BIOCORNEUM. The miraDry segment focuses on sales of the miraDry System, consisting of a console and a handheld device which uses consumable single-use bioTips. The company was founded by Hani M. Zeini in August 29, 2003 and is headquartered in Santa Barbara, CA.

Employees: 259